Safic-Alcan, a global distributor of specialty chemicals, announced the acquisition of a majority stake in S.A. Ingredients Private Limited (SAI). The strategic move strengthens Safic-Alcan’s presence in India’s rapidly growing pharmaceutical and nutraceutical sectors. S.A. Ingredients was established in September 2023 following the demerger of the distribution business from S.A. Pharmachem Private Limited (SAP), a Mumbai-headquartered company with operations dating back to 1992. SAI serves more than 400 customers across the pharmaceutical and nutraceutical industries. Moreover, the company collaborates with globally reputed principals and operates with a team of over 30 professionals, ensuring consistent service and technical expertise.
Strategic Expansion in Asia and Life Sciences
Commenting on the acquisition, Yann Lissillour, CEO of Safic-Alcan Group, emphasized that the deal aligns with the company’s long-term growth strategy in Asia. He noted that India’s strong GDP growth and expanding healthcare sector make it a critical market for future expansion. Additionally, S.A. Ingredients brings complementary capabilities, particularly in probiotics, pharmaceutical excipients, and nutraceutical ingredients. Importantly, the acquisition also builds on Safic-Alcan’s recent investment in Avees Biocos, further strengthening its Life Sciences platform in the region.
Capitalising on High-Growth Market Opportunities
Laurent Nataf, Managing Director – M&A at Safic-Alcan Group, highlighted the strong growth potential of the probiotics segment, which is projected to grow at around 20% annually. He added that S.A. Ingredients is well-positioned to capitalise on this opportunity due to its long-standing relationships with key principals. As a result, the combined entity will be able to deliver more specialised solutions and enhanced services to both customers and partners.
Leadership Perspective: Growth with Continuity
Gaurav Kabra, Managing Director of S.A. Ingredients, stated that joining Safic-Alcan will accelerate the company’s growth trajectory. He further emphasized that the partnership provides access to a global network, advanced resources, and industry expertise. At the same time, the company will continue to uphold its strong service commitment and operational continuity built over decades.
Strengthening India’s Role in Global Life Sciences
As per the press release, the acquisition marks a significant step in Safic-Alcan’s strategy to expand its footprint in India and the Asia-Pacific region. By combining global capabilities with strong local expertise, the company is well-positioned to tap into the growing demand for specialty ingredients in pharmaceuticals and nutraceuticals.
